URBN
50
-2
HCA
48
2
PYPL
56
-4
AZO
53
3
PSA
63
2
OI
38
-5
SYK
68
4
WAT
64
7
MSFT
57
6
LEG
43
-7
COST
66
3
SJM
45
9
NWS
60
-4
EMC
56
-3
AMZN
59
3
MU
36
-6
TSCO
48
-3
EW
46
3
SLB
53
-3
PGR
68
3
URBN
50
-2
HCA
48
2
PYPL
56
-4
AZO
53
3
PSA
63
2
OI
38
-5
SYK
68
4
WAT
64
7
MSFT
57
6
LEG
43
-7
COST
66
3
SJM
45
9
NWS
60
-4
EMC
56
-3
AMZN
59
3
MU
36
-6
TSCO
48
-3
EW
46
3
SLB
53
-3
PGR
68
3
Financhill
Back

Barry Callebaut AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
35

BRRLY
Barry Callebaut AG

Last Price:
14.60
Seasonality Move:
-8.26%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.86
Seasonality Move:
14.88%
Sell
35
Barry Callebaut AG (BRRLY) is a Sell

Is Barry Callebaut AG a Buy, Sell or Hold?

  • The current Barry Callebaut AG [BRRLY] share price is $14.33. The Score for BRRLY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BRRLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRRLY Stock Price Chart

What is Barry Callebaut AG's stock price today?

  • The Barry Callebaut AG share price today is $14.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRRLY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRRLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 32.95 Sell
Chaikin Money Flow: -2121 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.88 - 17.36) Sell
Bollinger Bands (100): (15.68 - 17.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

BRRLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.81 Sell
20-day SMA: 15.75 Sell
50-day SMA: 16.93 Sell
200-day SMA: 16.24 Sell
8-day EMA: 14.86 Sell
20-day EMA: 15.57 Sell
50-day EMA: 16.35 Sell
200-day EMA: 16.61 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Barry Callebaut AG Earnings Growth & BRRLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Barry Callebaut AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):